Why Did Cara Delizia Leave So Weird, New Restaurant On Conesus Lake, Missionary Farewell Quotes, The Last Shift Filming Locations, Weaver Scope Mount For Henry Single Shot Rifle, Articles J

I would like at this point to make a transition to IB although I am not sure how. If you hover over the various sections of the donut, you will see the % breakdown of each score given. What should one expect in terms of an interview? Bankers are purely there for financial expertise and execution, rarely do they provide any product advice to the clients. Sint aut vel animi minus. Healthcare is generally broken down like this: Pharmaceuticals, which is further broken down into more mature companies with a wide portfolio of marketed drugs (Pfizer) and smaller biotech companies which may be listed publicly and have 9-figure valuations based solely on a product in clinical trials, despite no revenue. Use code at checkout for 15% off. It's kinda like dealbook for the biotech/pharma/medtech sectors, Healthcare IB - Interest has grown (Originally Posted: 05/08/2008). You can choose to be an Associate in CCB (coverage stuff) or LevFin (and officially be an employee of IBD rather than the Corporate Bank) though they naturally want you to stay CCB. But the deal volume in healthcare is expected to stay the same or even pickup during Q3 and Q4. Pharmas still need to fill their pipelines and several of this years biggest deals have been in devices. (Originally Posted: 01/23/2013). Omnis illo inventore est tempora sit aut. It's currently quite a "hot" industry as far as I'm aware. Do you think I would stand a chance of landing a position like this next summer if I have a 3.9 GPA in my UG Life Sci degree + fin courses. First, are there any aspects of deals in the healthcare sector that are unique in comparison to other sectors? I've been trying to find as much information as I can on the industry and have a very basic knowledge, but I'd like to see if the IB gurus here on WSO can help me out. Et neque dignissimos consectetur dolorum repellat velit quia. Global M&A Activity | J.P. Morgan The bank doesn't actually make money on this stuff (no one does), it's more of a loss leader for the institutional debt deals.